Year-end report 2017
SUMMARY OF THE PERIOD Important events during the fourth quarter 2017 · In December, Vicore Pharma Holding increased its holding in I-Tech AB through a share issue. · In December, Vicore Pharma submitted an application to the British authorities to start a phase IIa study in patients suffering from idiopathic pulmonary fibrosis (IPF). · In December, Vicore Pharma’s board member, Göran Arvidson, passed away. · In October, Vicore Pharma announced results from the in-depth analysis of the Phase I extension study. The results verified previously published data that C21 has